Advances in Cell Line Development and Production of Novel Modalities in Biopharmaceutical Manufacturing
Fill out the form below and we'll send your colleague an invitation to the "Advances in Cell Line Development and Production of Novel Modalities in Biopharmaceutical Manufacturing" event.
As demand for recombinant biologics and novel therapeutic modalities continues to grow, accelerating cell line development while maintaining high productivity is a critical challenge for biopharmaceutical manufacturers.
In this webinar, Professor Susan Sharfstein from the University at Albany, will explore recent advances in cell line development and production strategies, including high-throughput screening technologies, targeted transgene integration, and a novel transcription-based cell line selection approach.
The session will be complemented by an industry perspective from Maren Grün, Field Application Scientist for Thermo Fisher Scientific, who will provide an overview of Gibco™ cell culture media solutions and their role in supporting efficient, scalable monoclonal antibody production.
Together, these talks offer a comprehensive view of how cutting-edge science and practical manufacturing solutions are converging to accelerate biopharmaceutical development.
- Learn how high-throughput screening, targeted transgene integration, and transcription-based selection approaches can accelerate cell line development
- Understand how protein sequence design and AI-driven tools can improve expression, folding, and manufacturability of novel biotherapeutics
- Gain insight into Gibco™ cell culture media solutions designed to support efficient, scalable monoclonal antibody production
- Learn how optimized media formulations can enhance cell growth, productivity, and robustness across upstream bioprocesses
